These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17430797)

  • 1. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M
    J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung and autoimmune disease--therapy].
    Hauber HP; Zabel P
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of connective tissue disease.
    Ciavaglia SJ; Costello PB; Panara N
    Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunology of rheumatoid diseases.
    Koffler D
    Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
    [No Abstract]   [Full Text] [Related]  

  • 10. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell depletion therapy in rheumatic disease.
    Edwards JC; Cambridge G; Leandro MJ
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological therapies of autoimmune diseases.
    Kourbeti IS; Boumpas DT
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):41-6. PubMed ID: 15720235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular targeting in autoimmunity.
    Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
    Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cytokine antibodies for rheumatic diseases.
    Atzeni F; Sarzi-Puttini P
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1204-11. PubMed ID: 19876788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis.
    Huang CM; Yang YH; Chiang BL
    J Microbiol Immunol Infect; 2004 Apr; 37(2):88-94. PubMed ID: 15181489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
    Atzeni F; Sarzi-Puttini P; Doria A; Iaccarino L; Capsoni F
    Autoimmun Rev; 2005 Mar; 4(3):144-52. PubMed ID: 15823500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural involvement in systemic autoimmune disorders.
    Bouros D; Pneumatikos I; Tzouvelekis A
    Respiration; 2008; 75(4):361-71. PubMed ID: 18477860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.